23 Sep 2026 | 5 Mins Read
AI Wearable for Cancer Screening Achieves Success in Final Clinical Trials
Flipitmoney
Lord’s Mark Industries has approved final clinical trials in the USA, Great Britain, and Europe for its AI-enabled wearable breast cancer screening technology. Commercial placement is targeted for April 2027, contingent on successful validation and regulatory approvals. The technology aims to enhance early detection of breast cancer through advanced, non-invasive screening methods.